Protein nanospheres for gene delivery

Cold Spring Harbor Protocols

Volumn 3, Issue 1, 2008, Pages

  Kommareddy, Sushma ^a   Amiji, Mansoor M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GOLD; NANOCARRIER; NANOSPHERE; PLASMID DNA;

ARTICLE; BIOTECHNOLOGICAL PRODUCTION; CELL MIGRATION; GENE TRANSFER; GENETIC TRANSFECTION; NANOENCAPSULATION; NANOFABRICATION; NONVIRAL GENE DELIVERY SYSTEM; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 44949151920     PISSN: None     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top30     Document Type: Article

References (49)

1. Barratt, G. 2003. Colloidal drug carriers: Achievements and perspectives. Cell. Mol. Life Sci. 60: 21-37.
2. Brigger, I., Dubernet, C., and Couvreur, P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Delivery Rev. 54: 631-651.
3. Brzoska, M., Langer, K., Coester, C., Loitsch, S., Wagner, T.O., and Mallinckrodt, C. 2004. Incorporation of biodegradable nanoparticles into human airway epithelium cells - In vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem. Biophys. Res. Commun. 318: 562-570.
4. Cascone, M.G., Barbani, N., Cristallini, C., Giusti, P., Ciardelli, G., and Lazzeri, L. 2001. Bioartificial polymeric materials based on polysaccharides. J. Biomater. Sci. Polym. Ed. 12: 267-281.
5. Cascone, M.G., Lazzeri, L., Carmignani, C., and Zhu, Z. 2002. Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J. Mater. Sci. Mater. Med. 13: 523-526.
6. Chuang, V.T., Kragh-Hansen, U., and Otagiri, M. 2002. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm. Res. 19: 569-577.
7. Coester, C.J., Langer, K., van Briesen, H., and Kreuter, J. 2000. Gelatin nanoparticles by two-step desolvation - A new preparation method, surface modifications and cell uptake. J. Microencapsul. 17: 187-193.
8. Courts, A. 1954. The N-terminal amino acid residues of gelatin. 2. Thermal degradation. Biochem. J. 58: 74-79.
9. Djagny, V.B., Wang, Z., and Xu, S. 2001. Gelatin: A valuable protein for food and pharmaceutical industries: Review. Crit. Rev. Food Sci. Nutr. 41: 481-492.
10. Douglas, S.J., Davis, and Illum, L. 1987. Nanoparticles in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 3: 233-261.
11. Farrugia, C.A. and Groves, M.J. 1999a. The activity of unloaded gelatin nanoparticles on murine melanoma B16F0 growth in vivo. Anticancer Res. 19: 1027-1031.
12. Farrugia, C.A. and Groves, M.J. 1999b. Gelatin behaviour in dilute aqueous solution: Designing a nanoparticulate formulation. J. Pharm. Pharmacol. 51: 643-649.
13. Flory, P.J. and Weaver, E.S. 1960. Helix-coil transitions in dilute aqueous collagen solutions. J. Am. Chem. Soc. 82: 4518-4525.
14. Frens, G. 1973. Controlled nucleation for the regulation of the particle size in monodisperse gold solution. Nat. Phys. Sci. 241: 20-22.
15. Goa, K.L. and Benfield, P. 1994. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 47: 536-566.
16. Gorman, C.M., Moffat, L.F., and Howard, H.F. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
17. Gupta, A.K., Gupta, M., Yarwood, S.J., and Curtis, A.S. 2004. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology, and cytoskeleton organisation of human fibroblasts. J. Control. Release 95: 197-207.
18. Horisberger, M. 1979. Evaluation of colloidal gold as a cytochemical marker for transmission and scanning electron microscopy. Biol. Cell 36: 253-258.
19. Kaul, G. and Amiji, M. 2002. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm. Res. 19: 1062-1068.
20. Kaul, G. and Amiji, M. 2004a. Biodistribution and targeting potential of poly(ethylene glycol)modified gelatin nanoparticles in subcutaneous murine tumor model. J. Drug Target. 12: 585-591.
21. Kaid, G. and Amiji, M. 2004b. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)modified gelatin nanoparticles.J. Pharm. Sci. 94: 184-198.
22. Kaul, G. and Amiji, M. 2005. Tumor-targeted gene delivery using poly(ethylene glycol)modified gelatin nanoparticles: In vitro and in vivo studies. Pharm Res. 22: 951-961.
23. Kaul, G., Lee-Parsons, C., and Amiji, M. 2003. Poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm. Eng. 23: 1-5.
24. Kim, K.J. and Byun, Y. 1999. Preparation and characterizations of self-assembled PEGylated gelatin nanoparticles. Biotechnol. Bioprocess Eng. 4: 210-214.
25. Kommareddy, S. and Amiji, M. 2005. Preparation and evaluation of thiol modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem. 16 1423-1432.
26. Kreuter, J. 1978. Nanoparticles and nanocapsules: New dosage forms in the nanometer size range. Pharm. Acta Helv. 53: 33-39.
27. Kreuter, J. 1994. Drug targeting with nanoparticles. Eur. J. Drug Metab. Pharmacokinet. 19: 253-256.
28. Kushibiki, T., Matsuoka, H., and Tabata, Y. 2004. Synthesis and physical characterization of poly(ethylene glycol)gelatin conjugates. Biomacromotecules 5: 202-208.
29. Lavasanifar, A., Samuel, J., and Kwon, G.S. 2002. Poly(ethylene oxide)block-poly(I-amino acid) micelles for drug delivery. Adv. Drug Delivery Rev. 54: 169-190.
30. Leo, E., Arletti, R., Forni, F., and Cameroni, R. 1997. General and cardiac toxicity of doxorubicin loaded gelatin nanoparticles. Farmaco 52: 385-388.
31. Leo, E., Cameroni, R., and Forni, F. 1999. Dynamic dialysis for the drug release evaluation from doxorubicingelatin nanoparticle conjugates. Int. J. Pharm. 180: 23-30.
32. Leong, K.W., Mao, H.Q., Truong-Le, V.L., Roy, K., Walsh, S.M., and August, J.T. 1998. DNA-polycation nanospheres as non-viral gene delivery vehicles.J. Control Release 53: 183-193.
33. Ma, J., Cao, H., Li, and Li, Y. 2002. Synthesis and characterization of poly(DL-lactide)-grafted gelatins as bioabsorbable amphiphillic polymers. J. Biomater. Sci. Polym. Ed. 13: 67-80.
34. Marty, J.J., Oppenheim, R.C., and Speiser, P. 1978. Nanoparticles - A new colloidal drug-delivery system. Pharm. Acta Helv. 53: 17-23.
35. Mehvar, R. 2000. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. J. Control Release 69: 1-25.
36. Michaelis, M., Langer, K., Arnold, S., Doerr, H.W., Kreuter, J., and Cinatl Jr., J. 2004. Pharmacological activity of DTPA linked to protein-based drug carrier systems. Biochem Biophys. Res. Commun. 323: 1236-1240.
37. Moghimi, S.M., Hunter, A.C., and Murray, J.C. 2001. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53: 283-318.
38. Oppheneium, R.C. 1986., Nanoparticulate drug delivery systems based on gelatin and albumin. In Polymeric nanoparticles and microspheres (eds. P Guiot and P Couvreur), pp. 1-25. CRC Press, Boca Raton, Florida.
39. Panyam, J. and Labhasetwar, V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Delivery Rev. 55: 329-347.
40. Soppimath, K.S., Aminabhavi, T.M., Kulkarni, A.R., and Rudzinski, W.E. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70: 1-20.
41. Speiser, P.P. 1991. Nanoparticles and liposomes: A state of the art. Methods Find. Exp. Clin. Pharmacol. 13: 337-342.
42. Suh, J.K. and Matthew, H.W. 2000. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials 21: 2589-2598.
43. Truong-Le, V.L., August, J.T., and Leong, K.W. 1998. Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene Ther. 9: 1709-1717.
44. Truong-Le, V.L., Walsh, S.M., Schweibert, E., Mao, H.Q., Guggino, W.B., August, J.T., and Leong, K.W. 1999. Gene transfer by DNA-gelatin nanospheres. Arch. Biochem. Biophys. 361: 47-56.
45. Vandervoort, J. and Ludwig, A. 2004. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur. J. Pharm. Biopharm. 57: 251-261
46. Weber, C., Coester, C., Kreuter, J., and Langer, K. 2000. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 194: 91-102.
47. Zillies, J. and Coester, C. 2005. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J. Pharm. Pharm. Sci. 7: 17-21.
48. Zwiorek, K., Kloeckner, J., Wagner, E., and Coester, C. 2004. In vitro gene transfection with surface modified gelatin nanoparticles. In Proceedings of the International Conference on MEMS and NANO and Smart Systems, August, 2004, pp. 60-63. IEEE Computer Society, Banff, Canada.
49. Zwiorek, K, Kloeckner, J., Wagner, E., and Coester, C. 2005. Gelatin nanoparticles as a new and simple gene delivery system. J. Pharm. Pharm. Sci. 7: 22-28.